Lexicon Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
LXRX
CUSIP
528872302
All holders as of
Q2 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 130 256 M $243 M
2025 Q1 135 266 M $122 M
2024 Q4 134 298 M $220 M
2024 Q3 144 289 M $453 M
2024 Q2 138 282 M $476 M
2024 Q1 129 173 M $419 M
2023 Q4 118 187 M $286 M
2023 Q3 119 189 M $206 M
2023 Q2 131 191 M $438 M
2023 Q1 111 146 M $354 M
2022 Q4 113 148 M $283 M
2022 Q3 106 149 M $358 M
2022 Q2 94 119 M $221 M
2022 Q1 109 120 M $251 M
2021 Q4 124 122 M $480 M
2021 Q3 105 121 M $583 M
2021 Q2 121 118 M $542 M
2021 Q1 116 121 M $712 M
2020 Q4 120 122 M $418 M
2020 Q3 100 104 M $150 M
2020 Q2 116 107 M $214 M
2020 Q1 125 105 M $205 M
2019 Q4 128 108 M $448 M
2019 Q3 117 103 M $311 M
2019 Q2 130 106 M $669 M
2019 Q1 137 104 M $582 M
2018 Q4 135 106 M $703 M
2018 Q3 138 108 M $1.16 B
2018 Q2 137 109 M $1.31 B
2018 Q1 137 110 M $943 M
2017 Q4 146 111 M $1.10 B
2017 Q3 154 115 M $1.41 B
2017 Q2 147 115 M $1.89 B
2017 Q1 149 114 M $1.64 B
2016 Q4 156 111 M $1.53 B
2016 Q3 152 110 M $2.00 B
2016 Q2 145 111 M $1.59 B
2016 Q1 135 111 M $1.32 B
2015 Q4 129 110 M $1.47 B
2015 Q3 109 106 M $1.14 B
2015 Q2 89 96.9 M $780 M